An Rh-Ve Mother delivered a Rh -Ve Baby, What is the dose of Anti-D?

NIMHANS Nursing Officer - 2019

Obstetrics and Midwifery Nursing

Medium

Appeared in: NIMHANS Nursing Officer - 2019

Explanation

Anti-D immunoglobulin is a medication given to prevent an Rh-negative mother from developing an immune response (sensitization) to Rh-positive blood cells.
This immune response is only triggered if the mother is exposed to the Rh(D) antigen, which is present on Rh-positive red blood cells.
In the given scenario, both the mother and the baby are Rh-negative. This means the baby's blood does not contain the Rh(D) antigen.
Since there is no exposure to the Rh antigen, there is no risk of the mother becoming sensitized.
Therefore, the administration of Anti-D immunoglobulin is not clinically indicated or required.

Option B: This dose is not required because the baby is Rh-negative, meaning there is no risk of maternal sensitization.
Option C: This is not a standard dose for routine postpartum prophylaxis against Rh sensitization.
Option D: The unit 'mg' (milligram) is incorrect; the standard dose is in 'mcg' (micrograms). 300 mg is 1000 times the standard dose and would represent a massive and dangerous overdose.

Clinical Relevance

Nursing practice connection: Knowing Indications and contraindications for postpartum Anti-D immunoglobulin (RhoGAM) administration helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
A critical nursing responsibility is to verify both the mother's and the newborn's blood type and Rh factor before administering Anti-D immunoglobulin. Administering it when not needed is an unnecessary medical intervention, while failing to administer it when indicated can have severe consequences for future pregnancies.
The principle 'When in doubt, give the shot' applies when the baby's Rh status is unknown, not when it is confirmed to be negative. If the baby's blood type cannot be determined, it is safer to administer Anti-D to prevent potential sensitization.
What if? If the baby had been Rh-positive, the nurse's priority action would be to administer the standard 300 mcg dose of Anti-D immunoglobulin intramuscularly to the mother within 72 hours of delivery to prevent sensitization.

How to Approach the Question

First, identify the key clinical information from the question: the mother's blood type (Rh-negative) and the baby's blood type (Rh-negative).
Recall the purpose of Anti-D immunoglobulin (RhoGAM): to prevent an Rh-negative mother from developing antibodies against Rh-positive blood.
Analyze the situation for Rh incompatibility. Since both mother and baby are Rh-negative, there is no incompatibility and no risk of sensitization.
Conclude that Anti-D administration is not necessary in this specific clinical scenario.
Review the given options. Recognize that the question is designed to test your understanding of the indication for Anti-D, not just the dose. The correct action is to give no dose.

Concept Tested & Keywords

Concept Tested: Indications and contraindications for postpartum Anti-D immunoglobulin (RhoGAM) administration.
Stem keywords: Rh-Ve Mother, Rh -Ve Baby, Anti-D, dose
Lead-in keywords: What is
Clinical cues: Mother is Rh-negative
Clinical cues: Baby is Rh-negative